Literature DB >> 12116009

Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada.

Yacine Abed1, Isabelle Hardy, Yan Li, Guy Boivin.   

Abstract

Limited information is available concerning the molecular drift of the influenza neuraminidase (NA) genes. We report on the genetic variability of the NA gene from 31 influenza A:H3N2 viruses isolated in the Province of Québec (Canada) during the last three flu seasons (1997-2000). Amino acid substitutions within the NA protein were observed at rates of 1.01% and 0.45% between strains of the 1997-1998 and 1998-1999 seasons and between those of the 1998-1999 and 1999-2000 seasons, respectively. In most strains (28/31), amino acid changes occurred within at least one of four codons (197, 339, 370, and 401) previously implicated as antigenic sites. The 8 functional and 10 framework residues that compose the catalytic site of the NA enzyme were completely conserved over the study period. All isolates contained the seven conserved asparagine-linked glycosylation sites found in the NA of the progenitor A/Hong Kong/8/68 strain. In addition, most strains (30/31) had an eighth potential glycosylation site at position 329, whereas a ninth one was found at position 93 in 16 strains. The NA of all strains in this study was related to that of the vaccine strain A/Beijing/353/89, whereas the HA genes of these strains were related to the A/Beijing/32/92 vaccine strain. Thus, it appears that recent influenza strains continue to evolve from a reassortant produced during the cocirculation of the two above variants. Interestingly, some strains whose HA genes were closely related showed significant differences in their NA genes and conversely. This study confirms the importance of analyzing both the NA and the HA genes to assess the evolution of recent influenza epidemic strains. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12116009     DOI: 10.1002/jmv.10143

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

1.  Diversifying evolution of highly pathogenic H5N1 avian influenza virus in Egypt from 2006 to 2011.

Authors:  E M Abdelwhab; Abdel-Satar Arafa; Jürgen Stech; Christian Grund; Olga Stech; Marcus Graeber-Gerberding; Martin Beer; Mohamed K Hassan; Mona M Aly; Timm C Harder; Hafez M Hafez
Journal:  Virus Genes       Date:  2012-06-05       Impact factor: 2.332

2.  Evolution of surface and nonstructural-1 genes of influenza B viruses isolated in the Province of Québec, Canada, during the 1998-2001 period.

Authors:  Yacine Abed; Michael B Coulthart; Yan Li; Guy Boivin
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

Review 3.  Advances in the development of influenza virus vaccines.

Authors:  Florian Krammer; Peter Palese
Journal:  Nat Rev Drug Discov       Date:  2015-03       Impact factor: 84.694

4.  Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets.

Authors:  Berend Jan Bosch; Rogier Bodewes; Robert P de Vries; Joost H C M Kreijtz; Willem Bartelink; Geert van Amerongen; Guus F Rimmelzwaan; Cornelis A M de Haan; Albert D M E Osterhaus; Peter J M Rottier
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

5.  Longitudinal analysis of genotype distribution of influenza A virus from 2003 to 2005.

Authors:  Annie Mak; Ronak Rahmanian; Victor Lei; David Lawrence; Mel Krajden; Robert C Brunham; Danuta Skowronski; Yan Li; Tim Booth; Swee Han Goh; Martin Petric
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

6.  Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial.

Authors:  Serge Durviaux; John Treanor; Jiri Beran; Xavier Duval; Meral Esen; Gregory Feldman; Sharon E Frey; Odile Launay; Geert Leroux-Roels; Janet E McElhaney; Andrzej Nowakowski; Guillermo M Ruiz-Palacios; Gerrit A van Essen; Lidia Oostvogels; Jeanne-Marie Devaster; Karl Walravens
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

7.  Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011.

Authors:  Kim B Westgeest; Colin A Russell; Xudong Lin; Monique I J Spronken; Theo M Bestebroer; Justin Bahl; Ruud van Beek; Eugene Skepner; Rebecca A Halpin; Jan C de Jong; Guus F Rimmelzwaan; Albert D M E Osterhaus; Derek J Smith; David E Wentworth; Ron A M Fouchier; Miranda de Graaf
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

8.  Broadly protective human antibodies that target the active site of influenza virus neuraminidase.

Authors:  Daniel Stadlbauer; Xueyong Zhu; Meagan McMahon; Jackson S Turner; Teddy J Wohlbold; Aaron J Schmitz; Shirin Strohmeier; Wenli Yu; Raffael Nachbagauer; Philip A Mudd; Ian A Wilson; Ali H Ellebedy; Florian Krammer
Journal:  Science       Date:  2019-10-25       Impact factor: 47.728

9.  Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic.

Authors:  A Lavenu; M Leruez-Ville; M-L Chaix; P-Y Boelle; S Rogez; F Freymuth; A Hay; C Rouzioux; F Carrat
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

10.  Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.

Authors:  Allen Zheng; Weina Sun; Xiaoli Xiong; Alec W Freyn; Julia Peukes; Shirin Strohmeier; Raffael Nachbagauer; John A G Briggs; Florian Krammer; Peter Palese
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.